PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042559
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042559
Intraoperative Radiation Therapy Market size was valued at US$ 112.52 Million in 2025, expanding at a CAGR of 7.68% from 2026 to 2033.
Intraoperative Radiation Therapy (IORT) is a specialized cancer treatment process where radiation is carried directly to the tumor spot during operation. When the surgeon eliminates the tumor, a measured dose of radiation is applied to the visible area before closing the surgical wound. This method helps aim remaining cancer cells precisely while reducing exposure to neighboring healthy tissues. It is mostly used in certain solid tumors where limited treatment can recover surgical consequences and sustenance faster clinical decision-making in cancer care. The adoption of IORT is maintained by rising cancer cases and the increasing focus on precise oncology care globally. Organizations such as the World Health Organization, Global Cancer Observatory highlight the essential for advanced cancer treatment approaches worldwide. The National Cancer Institute provides standardized clinical definitions and supports research frameworks for intraoperative radiation techniques, while the International Atomic Energy Agency promotes safe integration of radiation technologies in medical environments.
Intraoperative Radiation Therapy Market- Market Dynamics
Growing Shift Toward Precision and Single-Session Cancer Treatment
Increasing Move to precision and single-session cancer treatment is becoming an important factor for the market as modern cancer care is gradually focused on enhancing treatment accuracy while reducing patient problem. Traditional radiation therapy often involves multiple hospital visits over several weeks, which can be physically and emotionally difficult for patients. Governments are inspiring value-based and efficient care delivery models that support single-session treatments. The Germany Federal Ministry of Health emphasized integration of precision surgical technologies in cancer centers. In Japan, the Ministry of Health, Labour and Welfare has supported adoption of advanced intraoperative imaging and radiation systems in university hospitals.
In the same way, the South Korea Ministry of Health and Welfare has also promoted hospital modernization programs focusing on minimally invasive oncology procedures. From industry perception, Carl Zeiss Meditec continues expanding its INTRABEAM system installations in surgical oncology, while Accuray Incorporated has reported increased clinical use of compact radiation systems designed for targeted and efficient tumor treatment workflows. These advances demonstrate how requirement for precise, single-step cancer treatment is firming implementation of IORT.
The Global Intraoperative Radiation Therapy Market is segmented on the basis of Products, Application, Technology, End-Use, and Region.
Considering different products classification, market is differed into five classes. Systems/accelerators show an important role in the market as they form the core equipment that used to distribute measured radiation during surgical measures. These systems are essential for ensuring precision, dose accuracy, and real-time treatment delivery directly in the operating room, which makes them central to clinical adoption. Within the corporate network, Elekta reported increased installation of advanced radiation delivery systems in oncology centers, reflecting rising demand for integrated treatment platforms. Similarly, Varian, a Siemens Healthineers company also highlighted expanded use of its radiation therapy systems across hospital networks, supporting precision-based surgical oncology procedures
As per end-use category, market varies into three types: specialty cancer centers, hospitals & clinics and ambulatory centers. Hospitals & Clinics account for its share of operation because these facilities are naturally equipped with advanced surgical groups, radiation oncology departments, and multidisciplinary cancer care teams vital to perform intraoperative procedures. The availability of integrated infrastructure allows smoother coordination between surgeons, radiation oncologists, and imaging specialists, making them more suitable for complex cancer surgeries involving IORT. From the business view, GE Healthcare reported expanded deployment of surgical imaging and radiation support systems across hospital networks, enabling improved intraoperative workflows. Similarly, Brainlab also highlighted increased installation of digital operating room solutions in hospital settings to support image-guided radiation procedures.
Intraoperative Radiation Therapy Market- Geographical Insights
Comprehending regional healthcare outlines helps describe how adoption of advanced medical technologies varies across global markets. Among regions, Asia-Pacific plays an important role in this market, where cumulative cancer burden and development of oncology infrastructure are supporting regular adoption of innovative surgical radiation methods. According to the World Health Organization (WHO), International Agency for Research on Cancer (IARC), Asia records the highest number of new cancer cases globally, with over 9.5 million new cases in China alone and around 1.4 million in India annually, reflecting a strong patient base requiring advanced treatment pathways. The Government of Japan - Ministry of Health, Labour and Welfare has reported continued national funding toward precision cancer treatment technologies in university hospitals, supporting integration of intraoperative systems. In addition, the Government of India, Department of Health Research highlights expansion of tertiary cancer care centers under the National Cancer Grid, improving access to advanced radiotherapy tools. These developments collectively support increasing clinical acceptance of IORT as healthcare systems prioritize faster, targeted, and hospital-efficient cancer treatment approaches.
Beside Asia-Pacific, Europe is projected to register its growth, as it is supported by strong public healthcare systems and structured oncology planning. According to the World Health Organization (WHO) and International Atomic Energy Agency (IAEA) joint medical radiation database, Europe maintains one of the highest radiotherapy accessibility levels, with better equipment density and trained oncology workforce compared to many other regions, enabling faster adoption of advanced techniques like IORT. The IAEA Lancet Oncology Commission (2024) highlights that Europe contributes significantly to global radiotherapy capacity, with over 7,600 radiotherapy centres globally and a large share located in European healthcare systems, supporting advanced cancer treatment integration. The Eurostat also records that cancer is amongst the foremost causes of death in the region, strengthening constant government investment in oncology care modernization and hospital technology advancements.
Japan Intraoperative Radiation Therapy Market- Country Insights
Japan exhibits a developed oncology ecosystem where advanced radiation technologies are steadily joined into specialized cancer care hospitals and research organizations. In the field of cancer care, the country places its importance on minimally invasive surgical approaches combined with highly targeted radiation procedures. The Ministry of Health, Labour and Welfare reported that around 225,000 patients obtain radiation therapy annually and nearly 25% of newly diagnosed cancer patients experience radiation-based treatment, display national reliance on radiation oncology services. The National Cancer Center Japan highlights that its radiation oncology departments operate multiple high-precision systems including linear accelerators and image-guided platforms, supporting advanced procedures that align with IORT-type precision treatment models. On the industry side, Carl Zeiss Meditec (Japan operations) continues expanding adoption of its INTRABEAM system used in intraoperative radiation procedures in breast and brain tumor care, reflecting steady clinical uptake of compact IORT technology systems in Japanese hospitals.
The IORT space is gradually emerging over a balance of medical technology innovators, oncology device manufacturers, and hospital-focused solution providers. It is formed by increasing use of precision radiation systems in surgical surroundings, where hospitals prefer integrated tools that enhance accuracy and decrease treatment time. Key participants such as ZEISS Meditec, Sensus Healthcare, Accuray, Varian (Siemens Healthineers), and Elekta focus on improving imaging-guided radiation delivery and workflow integration within operating rooms. Their solutions are progressively accepted in cancer centers that aim to combine surgery and radiation in a single process.
Recent activity shows steady movement toward smarter and more adaptable systems. For instance, ZEISS Meditec has continued expanding clinical use of its INTRABEAM platform in breast and brain tumor procedures, supporting more precise single-session radiation delivery during surgery. Similarly, Elekta has strengthened its oncology ecosystem by enhancing treatment planning and adaptive radiation software tools used alongside intraoperative procedures, improving coordination between surgical and radiation teams. These developments reflect a gradual shift toward more integrated and patient-focused cancer treatment approaches.
In January 2026, IBA reported increased deployment of proton and radiation therapy systems, including accelerator-based solutions used in complex oncology procedures that overlap with intraoperative radiation workflows. The company expanded installations and service contracts across multiple oncology centers, supporting broader radiation infrastructure.
In Aril 2025, Carl Zeiss Meditec received regulatory clearance for its INTRABEAM 700 IORT system, expanding precision intraoperative radiation capabilities with improved imaging integration and surgical workflow compatibility. This development strengthens adoption of low-energy X-ray IORT systems in operating rooms, supporting more precise tumor bed irradiation.